144 related articles for article (PubMed ID: 38044329)
1. Uveal and conjunctival melanomas: disease course and outcomes in Chinese patients.
Chan JYY; Lam SC; Yuen HKL
Hong Kong Med J; 2023 Dec; 29(6):506-513. PubMed ID: 38044329
[TBL] [Abstract][Full Text] [Related]
2. Clinical spectrum, treatment and outcomes of uveal melanoma in a tertiary centre.
Wong W; Sundar G; Chee C; Zhao PS; Rajagopalan R; Gopal L
Singapore Med J; 2019 Sep; 60(9):474-478. PubMed ID: 31197380
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics of UM and Association of Metastasis of Uveal Melanoma with Congenital Oculocutaneous Melanosis in Asian Patients: Analysis of 1151 Consecutive Eyes.
Zhou N; Zhang R; Liu Y; Wei W
Ophthalmol Retina; 2021 Nov; 5(11):1164-1172. PubMed ID: 33444806
[TBL] [Abstract][Full Text] [Related]
4. Uveal Melanoma Metastasis to the Contralateral Eye Structures: A Retrospective Comparative Analysis of 13 Consecutive Patients.
Masoomian B; Mashayekhi A; Shields JA; Shields CL
Ophthalmol Retina; 2021 Oct; 5(10):1036-1042. PubMed ID: 33421627
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.
Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y
Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584
[TBL] [Abstract][Full Text] [Related]
6. Conjunctival and uveal melanoma: Survival and risk factors following orbital exenteration.
Baum SH; Westekemper H; Bechrakis NE; Mohr C
Eur J Ophthalmol; 2022 Jan; 32(1):612-619. PubMed ID: 33573425
[TBL] [Abstract][Full Text] [Related]
7. Mortality after uveal and conjunctival melanoma: which tumour is more deadly?
Kujala E; Tuomaala S; Eskelin S; Kivelä T
Acta Ophthalmol; 2009 Mar; 87(2):149-53. PubMed ID: 18937804
[TBL] [Abstract][Full Text] [Related]
8. Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma.
Strobel K; Bode B; Dummer R; Veit-Haibach P; Fischer DR; Imhof L; Goldinger S; Steinert HC; von Schulthess GK
Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1774-82. PubMed ID: 19495748
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of ocular and oculodermal melanocytosis in Spanish population with uveal melanoma.
Carreño E; Saornil MA; Garcia-Alvarez C; Lopez-Lara F; De Frutos-Baraja JM; Almaraz A
Eye (Lond); 2012 Jan; 26(1):159-62. PubMed ID: 22020174
[TBL] [Abstract][Full Text] [Related]
10. Comparing the Hem- and Lymphangiogenic Profile of Conjunctival and Uveal Melanoma Cell Lines.
Refaian N; Schlereth SL; Koch KR; Notara M; Hos D; Mescher M; Iden S; Bosch JJ; Jager MJ; Cursiefen C; Heindl LM
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5691-7. PubMed ID: 26313304
[TBL] [Abstract][Full Text] [Related]
11. Ocular melanoma-when you have seen one, you have not seen them all: a clinical outcome study from the Surveillance, Epidemiology and End Results (SEER) database (1973-2012).
Mahendraraj K; Shrestha S; Lau CS; Chamberlain RS
Clin Ophthalmol; 2017; 11():153-160. PubMed ID: 28115829
[TBL] [Abstract][Full Text] [Related]
12. Interdisciplinary Surveillance of Ocular Melanomas: Experiences in a German Tertiary Centre.
Mor JM; Rokohl AC; Mauch C; Heindl LM
Klin Monbl Augenheilkd; 2021 Jan; 238(1):85-91. PubMed ID: 33242884
[TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy.
Wang H; Zhang R; Wang Y; Chen R; Liu Y; Li Y; Wei W
BMC Ophthalmol; 2022 Apr; 22(1):163. PubMed ID: 35397506
[TBL] [Abstract][Full Text] [Related]
14. Primary bilateral uveal melanoma: a population-based study and systematic review.
Scott JF; Vyas R; Galvin J; Gotow E; Fiessinger L; Gerstenblith AT; Gerstenblith MR
Clin Exp Ophthalmol; 2018 Jul; 46(5):502-510. PubMed ID: 29219254
[TBL] [Abstract][Full Text] [Related]
15. Uveal metastasis revealing lung cancer.
Meziani L; Cassoux N; Le Rouic LL; Gabriel CL; Dendale R; Sastre X; Catherine D; Livartowski A; Plancher C; Asselain B; Desjardins L
J Fr Ophtalmol; 2012 Jun; 35(6):420-5. PubMed ID: 22633214
[TBL] [Abstract][Full Text] [Related]
16. Risk factors, clinical outcomes, and natural history of uveal melanoma: a single-institution analysis.
Delgado-Ramos GM; Thomas F; VanderWalde A; King B; Wilson M; Pallera AM
Med Oncol; 2019 Jan; 36(2):17. PubMed ID: 30666496
[TBL] [Abstract][Full Text] [Related]
17. Non-ocular primary malignancies in patients with uveal melanoma: the Liverpool experience.
Heussen FM; Coupland SE; Kalirai H; Damato BE; Heimann H
Br J Ophthalmol; 2016 Mar; 100(3):356-9. PubMed ID: 26178903
[TBL] [Abstract][Full Text] [Related]
18. Ocular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist.
Martorano LM; Winkelmann RR; Cebulla CM; Abdel-Rahman MH; Campbell SM
Int J Dermatol; 2014 Jun; 53(6):657-63. PubMed ID: 24697775
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Factors Five Years After Enucleation for Uveal Melanoma.
Dogrusöz M; Brouwer NJ; de Geus SJR; Ly LV; Böhringer S; van Duinen SG; Kroes WGM; van der Velden PA; Haasnoot GW; Marinkovic M; Luyten GPM; Kivelä TT; Jager MJ
Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):31. PubMed ID: 32186672
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and management of uveal melanoma.
Yonekawa Y; Kim IK
Hematol Oncol Clin North Am; 2012 Dec; 26(6):1169-84. PubMed ID: 23116575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
